Annovis Bio Shows Promise on FDA Clearance for Alzheimer's Drug

Published on 18 Oct 2024 on GuruFocus.com · via Yahoo Finance

Oct. 17, 2024 The market is enthusiastic to Annovis Bio, Inc. (NYSE:ANVS) and some say that they...

Read the rest of the article

Start tracking your investments with Statfolio

Oct. 17, 2024 The market is enthusiastic to Annovis Bio, Inc. (NYSE:ANVS) and some say that they...

GuruFocus.com · via Yahoo Finance 18 Oct 2024

Candel Therapeutics CADL, a clinical-stage oncology company, is focused on developing two novel t...

Zacks via Yahoo Finance 28 May 2024

Shares of Annovis Bio, Inc. (ANVS) have gained 0.1% over the past four weeks to close the last tr...

Zacks via Yahoo Finance 28 May 2024

Verastem Oncology VSTM announced positive interim safety and efficacy data from the dose level 1 ...

Zacks via Yahoo Finance 24 May 2024

Xenon Pharmaceuticals Inc. XENE reported a loss of 62 cents per share in the first quarter of 202...

Zacks via Yahoo Finance 10 May 2024

Bio-Path Holdings, Inc. BPTH announced that it has completed the second dose cohort in the dose-e...

Zacks via Yahoo Finance 19 Apr 2024

Investors in Annovis Bio, Inc. ANVS need to pay close attention to the stock based on moves in th...

Zacks via Yahoo Finance 18 Mar 2024

Key Insights Significant control over Annovis Bio by individual investors implies that the genera...

Simply Wall St. via Yahoo Finance 24 Jan 2024

In this piece, we will take a look at these stocks under $10 are poised to explode. If you want t...

Insider Monkey via Yahoo Finance 21 Dec 2023

Annovis Bio ANVS is a clinical-stage drug platform company addressing neurodegenerative diseases,...

Zacks via Yahoo Finance 1 Dec 2023